Company Data

Novavax Inc.

Ticker
NVAX
Current Price
$6.92 -6.23%
Market Cap
$1.1B
Price Target
Refer to Report
Volume
7.9M
52wk Range
$5.01 - $23.8599
Advanced Market Data

Overview

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. Novavax develops product candidates geared toward all age demographics of the general population.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy